AGP Executive Report
Last update: 9 hours agoProduct Safety: The American Medical Association is urging the FDA to apply rigorous drug-safety standards to botanical products, including cannabis, and require strong clinical testing and ongoing safety monitoring. Edible Risks: After a family, including a two-year-old, was hospitalised in Thailand after eating cannabis sweets, police seized 90 unlabelled gummies; authorities are testing samples for THC and CBD. New York officials also urged families to lock edibles away from children and keep them separate from Halloween treats. Medical Access: Nepal’s Supreme Court has ordered the government to create rules for controlled cannabis cultivation for medical and other uses, potentially opening a path to legal production after decades of prohibition. In the UK, an artist with epilepsy who benefited from medical cannabis in the Netherlands still cannot access it through the NHS, and his medication’s manufacturer has gone bankrupt.Regulatory Watch: Cannabis brands face compliance risks beyond lab testing, including packaging, advertising and sales practices.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
